Patenting transcription factors for drug discovery and therapeutics

Author： Manning A.M. Gonzales R. Bennett B.L.

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.3, 1997-03, pp. : 225-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The landscape of drug discovery in atherosclerosis and dyslipidaemia revisited: an update of patenting activity

By Suckling Keith

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 3, 2012-03 ,pp. : 199-204

Informa Healthcare

Access to resources Recommend Favorite

The landscape of drug discovery in atherosclerosis and dyslipidaemia: a survey from patenting activity

By Suckling Keith

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 5, 2008-05 ,pp. : 473-484

Informa Healthcare

Access to resources Recommend Favorite

Patenting of therapeutics for obesity and nutritional disease

By Nelson J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. : 1185-1196

Informa Healthcare

Access to resources Recommend Favorite

Searching for Therapeutics Against Botulinum Neurotoxins: A True Challenge for Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 21, 2016-06 ,pp. : 2330-2349

Bentham Science Publishers

Access to resources Recommend Favorite

Five years of drug patenting

By Steele P. Nelson J.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 3, 1999-03 ,pp. : 223-230

Informa Healthcare

Access to resources Recommend Favorite